| 000 | 01859 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514063855.0 | ||
| 264 | 0 | _c20030820 | |
| 008 | 200308s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 024 | 7 |
_a10.1074/jbc.M303093200 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrown, Jillian R | |
| 245 | 0 | 0 |
_aExpression patterns of alpha 2,3-sialyltransferases and alpha 1,3-fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoys. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cJun 2003 |
||
| 300 |
_a23352-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBlood Platelets _xchemistry |
| 650 | 0 | 4 |
_aCell Adhesion _xdrug effects |
| 650 | 0 | 4 |
_aColonic Neoplasms _xenzymology |
| 650 | 0 | 4 |
_aDisaccharides _xmetabolism |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFucosyltransferases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeoplastic Cells, Circulating _xdrug effects |
| 650 | 0 | 4 |
_aOligosaccharides _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRNA, Neoplasm _xanalysis |
| 650 | 0 | 4 |
_aSelectins _xmetabolism |
| 650 | 0 | 4 | _aSialyl Lewis X Antigen |
| 650 | 0 | 4 |
_aSialyltransferases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 | _abeta-Galactoside alpha-2,3-Sialyltransferase |
| 700 | 1 | _aFuster, Mark M | |
| 700 | 1 | _aWhisenant, Thomas | |
| 700 | 1 | _aEsko, Jeffrey D | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 278 _gno. 26 _gp. 23352-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.M303093200 _zAvailable from publisher's website |
| 999 |
_c12478622 _d12478622 |
||